CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2 Pilot Randomized Controlled Trial Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm Patients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04243122
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:29.798367+00:00
Published At: 2024-05-29T00:00:00+00:00
Record Updated At: 2024-05-29
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Myeloproliferative Neoplasm (MPN)", "Essential Thrombocythemia (ET)", "JAK2 Mutation", "Polycythemia Vera (PV)", "Primary Myelofibrosis", "Venous Thromboembolism (VTE)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-05-29"
protocolSection.identificationModule.nctId: "NCT04243122"
protocolSection.identificationModule.officialTitle: "A Phase 2 Pilot Randomized Controlled Trial Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm Patients"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.